New Drug Application (NDA) for hyperphosphatemia in chronic kidney disease patients on dialysis under review by FDA with PDUFA target action date of June 28, 2025; ongoing ...

Cardiac surgery brings in millions of dollars for health systems—but a common, costly complication is quietly eating at the profits.

Although much remains to be done, tremendous progress has been made on the prevention and control of chronic non-communicable diseases (NCDs), with slow but steady health gains achieved for millions ...

Alarming studies reveal energy drinks, popular among young individuals in the UK (31%), pose significant health risks.

New research disentangles the risks for acute kidney injury related to CAR T-cell treatment in non-Hodgkin lymphoma, ...

Based on updated definitions, SA-AKI affects nearly half of all patients with sepsis in the ICU and one‑sixth of all ICU ...

A recent study found that COVID-19 hospitalization for patients with CKD increased the risk for poor long-term adverse kidney ...

Scientists believe they know what causes the treated infection to mimic chronic illness ... Symptoms that persist long after Lyme disease is treated are not uncommon -- a 2022 study found that ...

Advanced CKD was linked to a higher likelihood of both fatal and non-fatal adverse outcomes after acute myocardial infarction treatment. Patients with advanced chronic kidney disease (ACKD) with acute ...

The effects of acute exposure include lung irritation, and chronic inhalation or oral exposure can lead to kidney disease. It ...

In the U.S., more than 1 in 7 adults has chronic kidney disease. That does not account for those with undiagnosed kidney ...